Late hyporegenerative anemia in neonates with rhesus hemolytic disease - PubMed (original) (raw)
Late hyporegenerative anemia in neonates with rhesus hemolytic disease
S al-Alaiyan et al. J Perinat Med. 1999.
Abstract
This study was conducted to determine the risk factors of the late hyporegenerative anemia in Rh-isoimmunized infants. Data on 36 infants with rhesus hemolytic disease were analyzed. The mean gestational age and birth weight were 36 +/- 1.3 weeks and 2837 +/- 403 grams respectively. Twenty-seven infants (75%) received between 2 and 8 intravascular intrauterine blood transfusions. Fourteen infants (39%) required simple packed red blood cell transfusions and 11 infants (31%) required exchange blood transfusion in the immediate postnatal period. Thirty infants (83%) developed late anemia and required blood transfusions at a mean postnatal age of 43.3 +/- 15.7 days. Sixty-four percent of infants who had exchange blood transfusions did not develop late anemia, while 92% of infants who did not require exchange blood transfusion developed late anemia, and the difference was statistically significant (P = 0.035). Serum erythropoietin levels were determined in 8 infants immediately before simple transfusion for late anemia. The media serum erythropoietin level was 21.2 mU/ml, ranging between less than 10 to 114.2 mU/ml. We conclude that late hyporegenerative anemia is common among Rh isoimmunized infants, regardless of the intravascular intrauterine transfusion. Exchange blood transfusion was associated with less occurrence of late anemia.
Similar articles
- Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study).
Ovali F, Samanci N, Dağoğlu T. Ovali F, et al. Pediatr Res. 1996 May;39(5):831-4. doi: 10.1203/00006450-199605000-00015. Pediatr Res. 1996. PMID: 8726237 Clinical Trial. - [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
Gobalakichenane P, Lardennois C, Galène-Gromez S, Brossard V, Marpeau L, Verspyck E, Marret S; le Réseau de périnatalité de Haute-Normandie. Gobalakichenane P, et al. Gynecol Obstet Fertil. 2008 Oct;36(10):984-90. doi: 10.1016/j.gyobfe.2008.07.012. Epub 2008 Sep 18. Gynecol Obstet Fertil. 2008. PMID: 18804397 French. - Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.
De Boer IP, Zeestraten EC, Lopriore E, van Kamp IL, Kanhai HH, Walther FJ. De Boer IP, et al. Am J Obstet Gynecol. 2008 Jan;198(1):54.e1-4. doi: 10.1016/j.ajog.2007.05.030. Am J Obstet Gynecol. 2008. PMID: 18166305 - Rh hemolytic disease of the newborn.
Page S. Page S. Neonatal Netw. 1989 Jun;7(6):31-41. Neonatal Netw. 1989. PMID: 2499756 Review. No abstract available. - Erythropoietin and prematurity--where do we stand?
Carbonell-Estrany X, Figueras-Aloy J, Alvarez E. Carbonell-Estrany X, et al. J Perinat Med. 2005;33(4):277-86. doi: 10.1515/JPM.2005.054. J Perinat Med. 2005. PMID: 16207112 Review.
Cited by
- Exchange transfusions in severe Rh-mediated alloimmune haemolytic disease of the foetus and newborn: a 20-year overview on the incidence, associated risks and outcome.
Ree IMC, Besuden CFJ, Wintjens VEHJ, Verweij JEJT, Oepkes D, de Haas M, Lopriore E. Ree IMC, et al. Vox Sang. 2021 Oct;116(9):990-997. doi: 10.1111/vox.13090. Epub 2021 Mar 17. Vox Sang. 2021. PMID: 33730387 Free PMC article. - Early-onset hypoproliferative anemia in an intrauterine-transfused neonate with severe Rh hemolytic disease.
Subramaniyan R. Subramaniyan R. Med J Armed Forces India. 2023 May-Jun;79(3):344-347. doi: 10.1016/j.mjafi.2021.05.004. Epub 2021 Jul 31. Med J Armed Forces India. 2023. PMID: 37193525 Free PMC article. - Novel device for automating exchange transfusions through umbilical venous route in neonates.
Chatterjee A, Verma S, Dutta S, Singh S, Singh G, Sharma RR, Sachdev S, Attri S, Bhatia P. Chatterjee A, et al. Eur J Pediatr. 2023 Mar;182(3):1229-1238. doi: 10.1007/s00431-022-04791-3. Epub 2023 Jan 10. Eur J Pediatr. 2023. PMID: 36625935 - Neonatal outcome after fetal anemia managed by intrauterine transfusion.
Garabedian C, Rakza T, Thomas D, Wibaut B, Vaast P, Subtil D, Houfflin-Debarge V. Garabedian C, et al. Eur J Pediatr. 2015 Nov;174(11):1535-9. doi: 10.1007/s00431-015-2573-x. Epub 2015 Jun 2. Eur J Pediatr. 2015. PMID: 26032762 - Hyporegenerative anemia and other complications of rhesus hemolytic disease: to treat or not to treat is the question.
Alaqeel AA. Alaqeel AA. Pan Afr Med J. 2019 Mar 14;32:120. doi: 10.11604/pamj.2019.32.120.17757. eCollection 2019. Pan Afr Med J. 2019. PMID: 31223410 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials